Advisory Committees

May 8, 2013: Vaccines and Related Biological Products Advisory Committee Meeting Draft Agenda

Food and Drug Administration
Center for Biologics Evaluation and Research
Vaccines and Related Biological Products Advisory Committee
133rd Meeting via Teleconference
Rockwall II, Conference Room 1033
5515 Security Lane, Rockville, MD
May 8, 2013

DRAFT AGENDA

 Open Session
1:00 p.m.Call to Order and Opening Remarks
Robert Daum, M.D., Chair

Conflict of Interest Statement
Donald Jehn, M.S., FDA
Topic I
Presentation of Laboratory of DNA Viruses,
Division of Viral Products,
Office of Vaccines Research and Review,
Center for Biologics Evaluation and Research
1:15Overview of Research/Site Visit Process,
Carolyn Wilson, Ph.D., FDA
Center Biologics Evaluation and Research (CBER)
1:35Overview Division of Viral Products, OVRR
Jerry Weir, Ph.D., FDA
1:50Overview Laboratory of DNA Viruses
Keith Peden, Ph.D., FDA
2:20Open Public Hearing
3:20Closed Session
4:00Adjourn Meeting

Page Last Updated: 08/14/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.